ArticleBMC cancer2021

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.

Reid P Bissonnette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.